Biotech Survives in a Changing Environment
The Burrill Report submits: As the biotechnology industry gathers in Chicago this week for its largest annual convention, it finds itself in a vastly improved state from a year ago. Once again, to the surprise of many, biotech companies have proved to be more resilient than thought. Through a combination of cost-cutting, creative financing, and a willingness to accept deals on less favorable terms, many companies have managed to live to fight another day.Complete Story » seekingalpha.com |
Obama Warns Insurers on Rates
Obama told health-insurance executives they should keep a lid on big rate increases, but the executives said some rises were unavoidable because the new health law requires them to offer better benefits. online.wsj.com |
Margolin Leaves WellPoint
Leslie Margolin, the president of WellPoint's Anthem Blue Cross unit in California, is leaving the insurer to lead a new state health-care coalition. online.wsj.com |
Small Cap Biotech Stocks: 7 Picks, 1 Big Concern
Peter Navarro submits: Why I Like Biotech Stocks Biotech stocks are great to trade in a sideways market because they move mostly on science, not the economy.Biotech stocks have high risk but high reward – my 15-bagger of the year was Prolor Biotech (PBTH.OB), which went from 40 cents to 7 bucks and now trades on the Amex. How to Find Biotech Stocks Complete Story » seekingalpha.com |
HistoRx Recognized as a 2010 Company to Watch by the Connecticut Technology Council
[PR Newswire] - HistoRx was recognized as a 2010 Company to Watch by the Connecticut Technology Council at the Innovation Pipeline Awards ceremony last week in New Haven, Connecticut. Â HistoRx was recognized for significant milestones achieved in 2010: us.rd.yahoo.com |